Direct oral anticoagulants (DOACs) have revolutionized the field of anticoagulation in the
last decade, mainly due to their fixed dosing, rapid onset of anticoagulant effect, and non …

During the last decade, utilization of direct oral anticoagulants (DOACs) has increased due
to their pharmacokinetic profile and the fact that they are non-inferior to warfarin in the …

Anticoagulation is essential for treating venous thromboembolism (VTE) and preventing
systemic embolism in many cardiovascular conditions. Until recently, vitamin K antagonists …

The direct-acting oral anticoagulants (DOACs) have been increasingly used over vitamin K
antagonists in recent years because they do not require monitoring and have an immediate …

Since 2008, when the first direct oral anticoagulants (DOACs) were introduced in the
Netherlands, there has been a steep rise in the number of patients using these new …

Anticoagulation is the cornerstone in the treatment of thromboembolic disorders. In the
intensive care unit (ICU), anticoagulation is often challenging as the balance between …

PURPOSE: To describe the current prescribing practices of concomitant Direct oral
anticoagulants (DOACs) and antiplatelet use in critically ill patients, both medical and …

The primary objective of this study was to describe the impact on bleeding rates of 2 different
strategies for transitioning from a direct oral anticoagulant (DOAC) to a parenteral …

Objective: To describe the current prescribing practices of direct oral anticoagulants
(DOACs) in intensive care unit (ICU) patients and the associated clinical outcomes …

Aims The management of patients treated with direct oral anticoagulants (DOACs) during
hospitalization is a common challenge in clinical practice. Although bridging is generally not …